MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Diabetes Treatment and Management
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

3,896 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
3,896 works in the cohort · of 4,299,418page 49 of 78

Labels cover 11 of 3,896 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 3,896 of 3,896 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affunlabeled
Metformin for Type 2 diabetes mellitus
Blair J. MacDonald, Ricky D. Turgeon, James McCormack
2024· review· en· Academic Emergency Medicine· Medicine
machine prediction:candidate · noneconsensus · none
3
citations
aboutno affunlabeled
Canagliflozin - Beginning of the journey
Sunil Pandey, Deepanjana Dass
2014· article· en· Journal of Pharmacy And Bioallied Sciences· Medicine
machine prediction:candidate · noneconsensus · none
3
citations
venueno affno abstractunlabeled
Chronic Kidney Disease in Diabetes
2013· article· en· Canadian Journal of Diabetes· Medicine
machine prediction:candidate · noneconsensus · none
3
citations
venueno affno abstractunlabeled
A strategy implementing initial therapy with a fixed- dose combination tablet of sitagliptin and metformin in patients with type 2 diabetes provides superior glycaemic control compared with a strategy using initial metformin monotherapy over 44 weeks
Leann Olansky, Charles A. Reasner, Thomas Seck, Debora Williams‐Herman, Edmund Luo, M. Chen +4 more
2009· article· en· Canadian Journal of Diabetes· Medicine
machine prediction:candidate · noneconsensus · none
3
citations
affvenueunlabeled
Drug eruption associated with empagliflozin
Kevin Yau, Stephanie Poon, Bourne L. Auguste
2022· article· en· Canadian Medical Association Journal· Medicine
machine prediction:candidate · noneconsensus · none
3
citations
afffundvenueaboutno abstractunlabeled
Glycemic Control and Cardiovascular Risk Factor Management in Adults With Type 2 Diabetes With and Without Chronic Kidney Disease Before Sodium-Glucose Cotransporter Protein 2 Inhibitors: Insights From the Diabetes Mellitus Status in Canada Survey
Hirmand Nouraei, Lawrence A. Leiter, Mary Tan, Anatoly Langer, Hwee Teoh, Alice Cheng +4 more
2021· article· en· Canadian Journal of Diabetes· Medicine
machine prediction:candidate · noneconsensus · none
3
citations
← previousnext →

How this was built: Screen · Findings · About